Article
Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients.
Indian journal of cancer - 1 Dec 2017
Doval D C, Deshpande R, Dhabhar B, Babu K G, Prabhash K, Chopra R, Sripada P V, Deshmukh C, Suryavanshi M
Abstract excerpt
More than 50% of non-small cell lung cancer (NSCLC) cases harbor an actionable mutation, and molecular testing at different intervals can help in personalized and targeted treatment. Core tissue biopsy and needle biopsy done at the time of diagnosis/disease progression are interventional, time-consuming and can affect the patients adversely. Noninterventional biomarker testing by liquid biopsy promises to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
